Compare GNFT & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
SES AI Corp is a pre-commercialization stage company engaged in the development and initial production of high-performance Lithium-Metal (Li-Metal) rechargeable battery technologies for electric vehicles (EVs), urban air mobility (UAM), which encompasses electric vehicle take-off and landing (eVTOL), and other applications. The company is an integrated Li-Metal battery manufacturer with capabilities in material, cell, module, AI-powered safety algorithms, and recycling.